These results suggest that enhanced macrophage phagocytosis of melanoma cells resistant to vemurafenib when CD47 is inhibited is associated with stronger phagocytic “eat-me” signals transmitted by the increased expression of CRT on the cell surface. Here, CALR is linked to melanoma.